NCT06605014

Brief Summary

The goals of this observational study are to test the reliability of a new, standardized physical examination method to identify motion problems within joints or groups of joints among adult asymptomatic volunteers and in patients hospitalized with stroke or stroke-like episodes (e.g., transient ischemic attack, TIA). The main questions this investigation aims to answer are:

  • Can different, independent providers reliability quantify motion pattern problems using a systematic approach called, The Functional Pathology of the Musculoskeletal System (FPMSS) model?
  • Are there differences in joint(s) motion patterns among asymptomatic volunteers, patients with TIA (people with brain disease without new neurologic disability), and recent ischemic stroke (patients with new stroke-related-disability, e.g., paralysis)?
  • Is there an association between joint(s) motion impairment severity and stroke survivor outcomes? Participants (asymptomatic and those with stroke) will undergo a set of repeated paired, musculoskeletal physical exams by independent providers blinded to each other's assessments and patient information. Researchers will compare the severity, location, and quantity of joint(s) motion impairment between these three groups with the physical examination methodology (FPMSS). Clinical information (e.g., test results, diagnoses, brain imaging, medical history) will be collected from patients admitted for TIA and stroke. Enrolled participants with recent stroke will complete a survey three months after hospitalization to determine their self-perceived quality-of-life.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
4mo left

Started Sep 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Sep 2023Aug 2026

Study Start

First participant enrolled

September 1, 2023

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

July 25, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 20, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

September 26, 2025

Status Verified

September 1, 2025

Enrollment Period

2.8 years

First QC Date

July 25, 2024

Last Update Submit

September 24, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Examiner Rater-Reliability

    Test intra- and inter-rater reliability in identifying osteopathic somatic dysfunction (joint(s) motion impairment) among asymptomatic volunteers, patients with TIA, and recently admitted patients with stroke.

    3 to 14 days

  • Functional Pathology of the Musculoskeletal System

    A total of 80 specific musculoskeletal examination tests are performed assessing the amount of available motion in the spine, upper extremities, lower extremities, and pelvis. Navigational Motions (i.e., whole upper limb motion at shoulder) are scored on a scale of 1-4 with one representing the least loss of motion and 4 representing the most and Component Motions (i.e., motion of foot at ankle) scored on a scale of 0-3 with 0 representing "normal motion" and 3 representing "no motion".

    3-14 days

  • National Institutes of Health Neuro-Quality of Life (QoL) survey

    Quantify self-reported health-related quality-of-life (QoL) 90 days after ischemic stroke. Patient response domain scores have a normative distribution and are compared against general population means (50, with a standard deviation of 10; range 10-90). Interpreting value responses above or below means are based on the specific questions - i.e., higher scores do not uniformly reflect improvement while lower scores do not necessarily reflect poorer status. Patient will receive a digitally distributed survey inquiring about QoL domains surrounding mobility, satisfaction with and ability to participate in social roles, mood, fatigue, anxiety, cognition.

    90 days

Study Arms (1)

SOMADC-AC Cohort

1. Asymptomatic adult volunteers 2. Patients admitted with TIA 3. Patients admitted with acute ischemic stroke

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

20 Asymptomatic adult volunteers (e.g., medical center employees) will be recruited to undergo paired, repeated osteopathic physical examinations and serve as controls. 20 disease controls (TIA) will undergo a single paired assessment by two independent raters 80 patients recently admitted with acute ischemic stroke will undergo repeated paired independent rater assessments throughout hospitalization.

You may qualify if:

  • adults ≥18 years
  • Admission diagnosis:
  • ischemic stroke OR
  • transient ischemic attack (TIA). A prior history of TIA but without stroke may be enrolled.
  • Neurologic stability or lack of significant deterioration (i.e. ∆ NIHSS\<4) for at least 24 hours (defined by clinical documentation and/or communication with provider team(s)) in stroke subjects
  • Able to sit upright, lie supine, and when able lateral recumbent left/right positions with assist independently or with minimal person assist
  • Anticipated length of stay greater \> or = 2 days for ischemic stroke. TIA patients average length of stay is \< 2 days, and can be enrolled in the study.

You may not qualify if:

  • Acute skeletal fracture or known dislocation; history of pathologic (osteoporotic or neoplastic) skeletal fracture of thoracic cage, hip/pelvis/sacrum, or vertebral column
  • Prior history of ICH, ischemic stroke, confirmed by imaging and/or clinical evaluation. Patients with imaging showing "chronic stroke" who have never received a diagnosis of stroke and/or have not been previously symptomatic may still be enrolled, based on the Investigator's clinical judgement.
  • Spinal column support brace (e.g. cervical collar)
  • Anticipated neurosurgical intervention during hospitalization: decompressive hemicraniectomy, hematoma evacuation (defined by clinical documentation and/or communication with provider team(s))
  • Current endotracheal intubation (\*note: extubated patients can be evaluated for eligibility)
  • History of spinal cord injury with residual neuromuscular or sensory disability
  • History of recent trauma within the past 30 days
  • Known ligament, musculotendinous, or bone lesion
  • Clinical condition that would interfere with execution of movement or palpatory diagnostic testing, e.g. chronic pain
  • History of spinal surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California Davis Medical Center

Sacramento, California, 95817, United States

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Alan Yee, D.O.

    University of California, Davis

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alan Yee, D.O.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
90 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 25, 2024

First Posted

September 20, 2024

Study Start

September 1, 2023

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

September 26, 2025

Record last verified: 2025-09

Locations